|
JYpartners |
[[µ¶ÀÏ°è Åõ¼® Àü¹®±â¾÷]] Sales&Marketing ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.02 |
|
|
JYpartners |
PD Product Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
(ÁÖ)¸®¿ÂÆÄÆ®³Ê½º |
Country Head, Manager, Sr./Jr. cra ±Û·Î¹ú Pharm/cro(ÀçÅÃ
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
12.01 |
|
|
(ÁÖ)ºê·£µå¹Ì |
´ë±â¾÷ Ç°Áú°ü¸® ¾à»ç ´ëÀü±Ù¹«
´ëÀü ´ë´ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
10.03 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Country Medical Director/À¯·´°èÇÕÀÛÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
3³â¡è |
ä¿ë½Ã |
04.06 |
|
|
ÆÄÀε崺·ÎµåÄÁ¼³Æà |
±Û·Î¹ú Á¦¾à»ç/ RA Specialist (Á¤±ÔÁ÷/¾à»ç)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
06.26 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
MSL(Oncology´ã´ç °úÂ÷Àå±Þ)/±Û·Î¹ú¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
4³â¡è |
ä¿ë½Ã |
03.11 |
|
|
ÄÚ¸®¾Æºê·¹ÀÎ ((ÁÖ)¿¡ÀÌÄ¡¾ËÇãºê) |
À¯¸í ÄÚ½º´Ú »óÀå Á¦¾à»ç Ç°Áú°ü¸® ¾à»ç
Ãæ³² õ¾È½Ã, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.04 |
|
|
¹Ý¼®½áÄ¡(ÁÖ) |
Áß°ßÁ¦¾à»ç / Á¦Á¦¿¬±¸ÆÀÀå
Ãæ³² ¾Æ»ê½Ã | ´ëÇпø(¼®»ç) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
7³â¡è |
ä¿ë½Ã |
10.18 |
|
|
ÄÚ¸®¾Æºê·¹ÀÎ ((ÁÖ)¿¡ÀÌÄ¡¾ËÇãºê) |
Medical Science Liasion
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.02 |
|
|
´õÁ¸Àâ |
À¯¸íCROȸ»ç-Medical Director (MD)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
2³â¡è |
ä¿ë½Ã |
07.06 |
|
|
¼¿ï¿Ü´ë½ºÄ«¿ìÆ® |
ÀǾàÇ° µµ¸Å Ç°Áú°ü¸® ¾à»ç´Ô
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.24 |
|
|
JYpartners |
Pharmacist ÀǾàÇ° µµ¸Å ¹× ¹°·ù¼¾ÅÍ Ç°Áú°ü¸® (¾à»ç ÆÄÆ®
°æ±â ÆòÅýÃ, °æ±â ¿À»ê½Ã | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.24 |
|
|
Uway Consulting |
±¹³»¹ÙÀÌ¿À±â¾÷ ¾à»ç(Ç°Áú°ü¸®) ä¿ë
´ëÀü À¯¼º±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
05.06 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Country Medical Director/À¯·´°èÇÕÀÛÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
5³â¡è |
ä¿ë½Ã |
03.11 |
|